A study to evaluate the efficacy and safety of 3 study drugs in treatment of patients with with any type of eczematous disorderassociated with underlying tinea / yeast infection
- Conditions
- eczematous disorder with underlying tinea/yeast infection
- Registration Number
- CTRI/2012/09/003000
- Lead Sponsor
- Abbott Healthcare Pvt Ltd
- Brief Summary
This study is done to evaluated the efficacy and safety of a combination of clobetasol, neomycin and miconazole versus combination of betamethasone, clotrimazole, neomycin versus combination of betamethasone, gentamicin, miconazole in patients with any type of eczematous disorder associated with underlying tinea / yeast infectionxml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 54
•Patients aged 18 years and above diagnosed with any type of eczematous disorder associated presenting clinical features of underlying tinea/yeast infection •Patients who agree to adhere to the study design •Patients who give their consent for participation in this study.
•Pregnant or lactating females •Indications for use of systemic therapy •Patients sensitive to corticosteroids •Patients who have immune deficiency, hepatic or renal impairment •Patients who have been on any therapy within 1 month prior to enrollment in the study •Patients who are using any other concomitant therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •Improvement in clinical score from baseline Baseline, Day3, Day5 and Day7
- Secondary Outcome Measures
Name Time Method •Improvement in scaling and inflammation •Improvement in burning and itching
Trial Locations
- Locations (1)
Anand Bhavan Clinic
🇮🇳Mumbai, MAHARASHTRA, India
Anand Bhavan Clinic🇮🇳Mumbai, MAHARASHTRA, IndiaDrHasmukh ShroffPrincipal investigator9820506431hjshroff@yahoo.com